The new coronavirus infection COVID-19 is an acute viral disease that affects primarily the upper respiratory tract. The etiological agent of COVID-19 is the SARS-CoV-2 RNA virus (Coronaviridae family, Betacoronavirus genus, Sarbecovirus subgenus). We have developed a high-affinity human monoclonal antibody, called C6D7-RBD, which is specific to the S protein receptor-binding domain (RBD) from the SARS-CoV-2 Wuhan-Hu-1 strain and exhibits virus-neutralizing activity in a test with recombinant antigens: angiotensin-converting enzyme 2 (ACE2) and RBD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154778 | PMC |
| http://dx.doi.org/10.32607/actanaturae.11849 | DOI Listing |
Publication Analysis
Top Keywords
human monoclonal
8
monoclonal antibody
8
protein receptor-binding
8
receptor-binding domain
8
characterization c6d7-rbd
4
c6d7-rbd human
4
antibody specific
4
specific sars-cov-2
4
sars-cov-2 protein
4
domain coronavirus
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!